Metagenomi Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/15/2026 | 1.06 M | $1.42 M | 100.00% | 2.81% | |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 787.90 K | $1.06 M | 25.38% | 2.09% |
| CATALIO CAPITAL MANAGEMENT, LP | 05/15/2026 | 528.99 K | $708.85 K | 0.00% | 1.41% |
| PEAPOD LANE CAPITAL LLC | 05/04/2026 | 516.76 K | $682.92 K | 3.84% | 1.37% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 496.77 K | $665.67 K | 12.55% | 1.32% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 395.80 K | $530.37 K | 0.00% | 1.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 382.15 K | $512.09 K | 100.00% | 1.02% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 358.20 K | $480.16 K | 17.09% | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 05/12/2026 | 264.39 K | $354.28 K | 0.00% | 0.70% |
| BLACKROCK, INC. | 05/13/2026 | 230.13 K | $308.38 K | 2.67% | 0.61% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 202.14 K | $270.87 K | 70.71% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 170.17 K | $228.03 K | 100.00% | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 170.10 K | $227.94 K | -27.67% | 0.45% |
| JANE STREET GROUP, LLC | 05/12/2026 | 151.44 K | $202.93 K | -65.09% | 0.40% |
| STATE STREET CORP | 05/15/2026 | 120.43 K | $161.37 K | 0.00% | 0.32% |
| RESOLUTE ADVISORS LLC | 05/07/2026 | 89.94 K | $120.53 K | 0.00% | 0.24% |
| MAN GROUP PLC | 05/15/2026 | 78.64 K | $105.37 K | 39.19% | 0.21% |
| NORTHERN TRUST CORP | 05/14/2026 | 75.17 K | $100.73 K | 0.00% | 0.20% |
| RBF CAPITAL, LLC | 05/18/2026 | 64.02 K | $85.79 K | 0.00% | 0.17% |
| BBR PARTNERS, LLC | 05/12/2026 | 53.40 K | $71.56 K | 0.00% | 0.14% |
| XTX TOPCO LTD | 05/15/2026 | 40.58 K | $54.38 K | -41.18% | 0.11% |
| FORTITUDE ADVISORY GROUP L.L.C. | 04/28/2026 | 37.19 K | $49.84 K | -4.00% | 0.10% |
| MORGAN STANLEY | 05/15/2026 | 27.57 K | $36.94 K | -53.81% | 0.07% |
| MARSHALL WACE, LLP | 05/15/2026 | 27.52 K | $36.88 K | -65.22% | 0.07% |
| CITADEL ADVISORS LLC | 05/15/2026 | 16.99 K | $22.77 K | -90.46% | 0.05% |
| LPL FINANCIAL LLC | 05/06/2026 | 16.83 K | $22.56 K | 49.01% | 0.04% |
| UBS GROUP AG | 05/05/2026 | 16.10 K | $21.57 K | -35.86% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 13.39 K | $17.95 K | 100.00% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 12.80 K | $17.15 K | -7.15% | 0.03% |
| 04/22/2026 | 12.50 K | $16.75 K | 0.00% | 0.03% | |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 11.73 K | $15.71 K | -55.90% | 0.03% |
| HRT FINANCIAL LP | 05/14/2026 | 10.67 K | $14.00 K | -3.76% | 0.03% |
| MEEDER ASSET MANAGEMENT INC | 05/07/2026 | 5.50 K | $7.37 K | 0.00% | 0.01% |
| FMR LLC | 05/15/2026 | 4.72 K | $6.32 K | -30.70% | 0.01% |
| US BANCORP \DE\ | 05/15/2026 | 4.50 K | $6.03 K | 0.00% | 0.01% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/08/2026 | 4.18 K | $5.60 K | -41.44% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 2.89 K | $3.87 K | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.60 K | $2.02 K | 0.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 04/30/2026 | 511 | $685 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 05/15/2026 | 500 | $670 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 500 | $660 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 307 | $411 | 0.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 05/15/2026 | 50 | $67 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 42 | $56 | -99.55% | 0.00% |
| CWM, LLC | 05/14/2026 | 25 | $34 | 100.00% | 0.00% |
| OPTIVER HOLDING B.V. | 06/02/2026 | 18 | $24 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 4 | $5 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
Metagenomi Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 66 institutional investors and hedge funds held shares of Metagenomi Therapeutics Inc.. The most heavily invested institutionals were:
RENAISSANCE TECHNOLOGIES LLC: 787,900
Catalio Capital Management, LP: 528,993
Peapod Lane Capital LLC: 516,761
TWO SIGMA INVESTMENTS, LP: 496,767
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 395,800
JACOBS LEVY EQUITY MANAGEMENT, INC: 382,153
17.18% of Metagenomi Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.28 M shares in the last 24 months. This purchase volume represents approximately $13.24 M in transactions.